Michael Schmidt
Stock Analyst at Guggenheim
(4.92)
# 67
Out of 5,182 analysts
129
Total ratings
70.19%
Success rate
55.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintains: Buy | $160 → $175 | $140.55 | +24.51% | 6 | Apr 14, 2026 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Buy | $6 → $10 | $3.96 | +152.53% | 5 | Apr 10, 2026 | |
| NBTX Nanobiotix | Maintains: Buy | $26 → $36 | $33.20 | +8.45% | 4 | Apr 2, 2026 | |
| CMPX Compass Therapeutics | Reiterates: Buy | $12 | $1.67 | +618.56% | 6 | Mar 24, 2026 | |
| CTMX CytomX Therapeutics | Maintains: Buy | $10 → $15 | $4.05 | +270.37% | 3 | Mar 18, 2026 | |
| GLUE Monte Rosa Therapeutics | Maintains: Buy | $34 → $30 | $18.72 | +60.26% | 3 | Mar 18, 2026 | |
| ERAS Erasca | Maintains: Buy | $12 → $20 | $9.11 | +119.54% | 2 | Mar 16, 2026 | |
| XFOR X4 Pharmaceuticals | Initiates: Buy | $12 | $4.11 | +192.33% | 1 | Mar 9, 2026 | |
| TNGX Tango Therapeutics | Maintains: Buy | $18 → $20 | $22.06 | -9.34% | 3 | Mar 6, 2026 | |
| ONC BeOne Medicines AG | Maintains: Buy | $400 → $410 | $290.80 | +40.99% | 5 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $26.09 | +53.34% | 4 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $35 | $22.95 | +52.51% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.76 | +152.10% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $125 | $99.10 | +26.14% | 7 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.78 | +164.55% | 6 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $9.45 | +90.48% | 6 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $9.82 | +52.75% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $35.87 | -52.61% | 1 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $30.05 | +49.75% | 2 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $15 | $23.34 | -35.73% | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $52 | $81.51 | -36.20% | 1 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $10 | $12.57 | -20.45% | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $20.63 | +55.11% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $5.40 | +159.26% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $22.77 | - | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $44.69 | -6.02% | 10 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $2.20 | - | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.17 | +286.85% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $27.92 | - | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $112 | $7.63 | +1,367.89% | 4 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.76 | - | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.25 | - | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.11 | - | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $11.62 | +192.60% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $2.24 | +1,063.31% | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.74 | - | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 | $28.05 | +185.20% | 5 | Feb 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.48 | - | 6 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $4 → $5.5 | $4.13 | +33.17% | 2 | Nov 7, 2017 |
Revolution Medicines
Apr 14, 2026
Maintains: Buy
Price Target: $160 → $175
Current: $140.55
Upside: +24.51%
Zentalis Pharmaceuticals
Apr 10, 2026
Maintains: Buy
Price Target: $6 → $10
Current: $3.96
Upside: +152.53%
Nanobiotix
Apr 2, 2026
Maintains: Buy
Price Target: $26 → $36
Current: $33.20
Upside: +8.45%
Compass Therapeutics
Mar 24, 2026
Reiterates: Buy
Price Target: $12
Current: $1.67
Upside: +618.56%
CytomX Therapeutics
Mar 18, 2026
Maintains: Buy
Price Target: $10 → $15
Current: $4.05
Upside: +270.37%
Monte Rosa Therapeutics
Mar 18, 2026
Maintains: Buy
Price Target: $34 → $30
Current: $18.72
Upside: +60.26%
Erasca
Mar 16, 2026
Maintains: Buy
Price Target: $12 → $20
Current: $9.11
Upside: +119.54%
X4 Pharmaceuticals
Mar 9, 2026
Initiates: Buy
Price Target: $12
Current: $4.11
Upside: +192.33%
Tango Therapeutics
Mar 6, 2026
Maintains: Buy
Price Target: $18 → $20
Current: $22.06
Upside: -9.34%
BeOne Medicines AG
Feb 27, 2026
Maintains: Buy
Price Target: $400 → $410
Current: $290.80
Upside: +40.99%
Feb 23, 2026
Maintains: Buy
Price Target: $45 → $40
Current: $26.09
Upside: +53.34%
Dec 16, 2025
Maintains: Buy
Price Target: $25 → $35
Current: $22.95
Upside: +52.51%
Nov 7, 2025
Initiates: Buy
Price Target: $12
Current: $4.76
Upside: +152.10%
Nov 3, 2025
Upgrades: Buy
Price Target: $125
Current: $99.10
Upside: +26.14%
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $3.78
Upside: +164.55%
Aug 13, 2025
Reiterates: Buy
Price Target: $18
Current: $9.45
Upside: +90.48%
Aug 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $9.82
Upside: +52.75%
Jul 8, 2025
Reiterates: Buy
Price Target: $17
Current: $35.87
Upside: -52.61%
Jun 24, 2025
Reiterates: Buy
Price Target: $45
Current: $30.05
Upside: +49.75%
May 23, 2025
Maintains: Buy
Price Target: $40 → $15
Current: $23.34
Upside: -35.73%
May 12, 2025
Reiterates: Buy
Price Target: $52
Current: $81.51
Upside: -36.20%
May 7, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $12.57
Upside: -20.45%
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $20.63
Upside: +55.11%
Mar 24, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $5.40
Upside: +159.26%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $22.77
Upside: -
Feb 12, 2025
Reiterates: Buy
Price Target: $42
Current: $44.69
Upside: -6.02%
Jan 22, 2025
Reiterates: Buy
Price Target: n/a
Current: $2.20
Upside: -
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $5.17
Upside: +286.85%
Oct 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $27.92
Upside: -
Sep 30, 2024
Upgrades: Buy
Price Target: $112
Current: $7.63
Upside: +1,367.89%
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.76
Upside: -
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.25
Upside: -
Jan 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.11
Upside: -
Nov 8, 2023
Maintains: Buy
Price Target: $40 → $34
Current: $11.62
Upside: +192.60%
May 18, 2021
Initiates: Buy
Price Target: $26
Current: $2.24
Upside: +1,063.31%
Apr 28, 2021
Downgrades: Neutral
Price Target: n/a
Current: $3.74
Upside: -
Feb 15, 2019
Upgrades: Outperform
Price Target: $80
Current: $28.05
Upside: +185.20%
Jan 17, 2019
Initiates: Outperform
Price Target: n/a
Current: $7.48
Upside: -
Nov 7, 2017
Maintains: Market Perform
Price Target: $4 → $5.5
Current: $4.13
Upside: +33.17%